In Brief: Genzyme Transgenics
This article was originally published in The Tan Sheet
Executive Summary
Genzyme Transgenics: Plans to develop a nutritional supplement or "nutraceutical" containing prolactin, "a protein normally produced by the body" with a "broad effect on the immune system," according to SBC Warburg Dillon Read analysts Mary Ann Gray, PhD, and Susan Burnett. Genzyme has produced the protein in the milk of transgenic animals. "Prolactin is also present in human milk and is thought to aid in the maturation of the immune systems in nursing infants," the analysts add. Nutritional supplements "face fewer hurdles and a shorter development timeline than traditional pharmaceuticals," they note...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning